Foghorn Therapeutics Inc (FHTX)vsRevolution Medicines Inc (RVMD)
FHTX
Foghorn Therapeutics Inc
$3.63
-8.68%
HEALTHCARE · Cap: $219.00M
RVMD
Revolution Medicines Inc
$155.69
+3.11%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Foghorn Therapeutics Inc generates 3704% more annual revenue ($28.22M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -266.9%. RVMD earns a higher WallStSmart Score of 24/100 (F).
FHTX
Avoid19
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -470.4% — below average capital efficiency
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : FHTX
The strongest argument for FHTX centers on Debt/Equity.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : FHTX
The primary concerns for FHTX are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
FHTX profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
FHTX carries more volatility with a beta of 2.89 — expect wider price swings.
FHTX is growing revenue faster at -45.1% — sustainability is the question.
FHTX generates stronger free cash flow (-25M), providing more financial flexibility.
Bottom Line
RVMD scores higher overall (24/100 vs 19/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Foghorn Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs that target genetically determined dependencies within the chromatin regulatory system. The company is headquartered in Cambridge, Massachusetts.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?